REGN
Regeneron Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$672.15-0.67%
Price as of Jul 20, 2026
REGN capital
Regeneron Pharmaceuticals, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -0.01x
- Debt / assets
- 0.07x
- Debt / EBITDA
- 0.47x
- Net debt / EBITDA
- -0.04x
Liquidity & coverage
- Current ratio
- 3.57x
- Quick ratio
- 2.96x
- Cash ratio
- 1.71x
- Interest coverage
- 75.61x
- EBITDA / interest
- 119.69x
- Working capital
- $13.1B
Cash & dividend
- FCF / debt
- 1.54x
- Cash flow / debt
- 1.85x
- Dividend per share
- $3.64
- Dividend yield
- 0.5%
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.